# Kyntra Bio, Inc.: Form 8-K, filed Nov 6, 2025

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2025-11-06
- Accepted by EDGAR: Nov 6, 2025, 21:11 ET
- Period: 2025-11-06
- Accession: 0001193125-25-269529
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000119312525269529/fgen-20251106.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000119312525269529/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000119312525269529/fgen-20251106.htm

Filed Nov 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-269529. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.